HUT74804A - Process for producing rhenium- and technecium-compounds containing new molekule-stuctures for localizing hypoxia, and pharmaceutical compositions containing them - Google Patents

Process for producing rhenium- and technecium-compounds containing new molekule-stuctures for localizing hypoxia, and pharmaceutical compositions containing them

Info

Publication number
HUT74804A
HUT74804A HU9203389A HU9203389A HUT74804A HU T74804 A HUT74804 A HU T74804A HU 9203389 A HU9203389 A HU 9203389A HU 9203389 A HU9203389 A HU 9203389A HU T74804 A HUT74804 A HU T74804A
Authority
HU
Hungary
Prior art keywords
aryl
alkyl
localizing
hypoxia
molekule
Prior art date
Application number
HU9203389A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9203389D0 (en
Inventor
Rocco Richard J Di
Karen Linder
David P Nowotnik
Adrian D Nunn
John P Pirro
Kondareddiar Ramalingam
William R Rumsey
R Squibb And Sons Inc E
Original Assignee
Bracco Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Int Bv filed Critical Bracco Int Bv
Publication of HU9203389D0 publication Critical patent/HU9203389D0/hu
Publication of HUT74804A publication Critical patent/HUT74804A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/38—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
HU9203389A 1991-10-29 1992-10-28 Process for producing rhenium- and technecium-compounds containing new molekule-stuctures for localizing hypoxia, and pharmaceutical compositions containing them HUT74804A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78448691A 1991-10-29 1991-10-29
CN93103893A CN1093084A (zh) 1991-10-29 1993-03-31 包含缺氧定位部分的铼和锝络合物

Publications (2)

Publication Number Publication Date
HU9203389D0 HU9203389D0 (en) 1993-01-28
HUT74804A true HUT74804A (en) 1997-02-28

Family

ID=36809246

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9203389A HUT74804A (en) 1991-10-29 1992-10-28 Process for producing rhenium- and technecium-compounds containing new molekule-stuctures for localizing hypoxia, and pharmaceutical compositions containing them

Country Status (18)

Country Link
EP (1) EP0544412B1 (de)
JP (1) JP3385048B2 (de)
CN (2) CN1071928A (de)
AT (1) ATE155691T1 (de)
AU (1) AU662361B2 (de)
CA (1) CA2081637C (de)
DE (1) DE69221084T2 (de)
DK (1) DK0544412T3 (de)
ES (1) ES2104848T3 (de)
FI (1) FI924914A7 (de)
GR (1) GR3024895T3 (de)
HU (1) HUT74804A (de)
IL (1) IL103353A (de)
MX (1) MX9206070A (de)
NO (1) NO304466B1 (de)
NZ (1) NZ244613A (de)
PL (1) PL296409A1 (de)
ZA (1) ZA927692B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5808091A (en) 1991-10-29 1998-09-15 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia localizing moiety
US5608110A (en) * 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
CA2168652A1 (en) * 1993-08-04 1995-02-16 Colin Mill Archer Radiometal complexes that localise in hypoxic tissue
IL111592A0 (en) * 1993-12-14 1995-01-24 Bracco Int Bv Stable multilayer lyophile
ES2114735T3 (es) * 1994-01-12 1998-06-01 Bracco Int Bv Ligandos y complejos metalicos de los mismos.
US5700825A (en) * 1995-03-31 1997-12-23 Florida State University Radiosensitizing diamines and their pharmaceutical preparations
US6060604A (en) * 1995-03-31 2000-05-09 Florida State University Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
DE69830057T2 (de) 1997-01-21 2006-06-29 Ge Healthcare Ltd., Little Chalfont MARKIERTE FAKTOR XIIIa SUBSTRATE
WO1998033935A1 (en) * 1997-01-31 1998-08-06 The University Of Alberta Method for detecting exogenous gene expression
US8562945B2 (en) 2008-01-09 2013-10-22 Molecular Insight Pharmaceuticals, Inc. Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
RU2498798C2 (ru) 2008-01-09 2013-11-20 Моликьюлар Инсайт Фармасьютикалз, Инк. Ингибиторы карбоангидразы iх
AU2010260195B2 (en) 2009-06-15 2014-11-20 Molecular Insight Pharmaceuticals, Inc. Process for production of heterodimers of glutamic acid
CA2775397A1 (en) * 2009-09-28 2011-03-31 University Of Kentucky Research Foundation Thiol-containing compounds for the removal of elements from contaminated milieu and methods of use
EP2800471A4 (de) 2012-01-06 2015-11-04 Molecular Insight Pharm Inc Metallkomplexe von poly(carboxyl)aminhaltigen liganden mit einer affinität für carboanhydrase ix
EP3939972A1 (de) 2013-01-14 2022-01-19 Molecular Insight Pharmaceuticals, Inc. Triazinbasierte radiopharmazeutika und strahlungsbildgebungsmittel
CN111372940A (zh) * 2017-09-19 2020-07-03 阿尔伯塔大学理事会 生物还原活化的化合物、其前药、放射性药物、组合物及其在包括癌症在内的低氧疾病的多模式治疗控制中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2093451B (en) * 1981-02-24 1984-10-31 May & Baker Ltd Nitroimidazole derivatives
US4615876A (en) * 1983-04-25 1986-10-07 Curators Of The University Of Missouri Macrocyclic complexes of technetium-99m for use as diagnostic radionuclides
US4638051A (en) * 1984-04-30 1987-01-20 The Johns Hopkins University Brain imaging radiopharmaceuticals
DE3687467T2 (de) * 1985-03-11 1993-04-29 Amersham Int Plc Komplexe von technetium-99m mit propylen-amin-oximen.
WO1989010759A1 (en) * 1988-04-29 1989-11-16 Mallinckrodt, Inc. Diaminedithiol chelating agents for radiopharmaceuticals
US4988496A (en) * 1988-05-31 1991-01-29 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US4925650A (en) * 1988-11-16 1990-05-15 Mallinckrodt, Inc. Technetium -99m complex for examining the renal function
US4986979A (en) * 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
DE3930674A1 (de) * 1989-09-11 1991-03-21 Diagnostikforschung Inst Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie

Also Published As

Publication number Publication date
CA2081637A1 (en) 1993-12-15
MX9206070A (es) 1993-04-01
EP0544412B1 (de) 1997-07-23
IL103353A0 (en) 1993-03-15
NZ244613A (en) 1996-05-28
NO924157L (no) 1993-04-30
EP0544412A3 (en) 1993-08-25
CN1071928A (zh) 1993-05-12
ES2104848T3 (es) 1997-10-16
AU2737392A (en) 1993-05-06
DK0544412T3 (da) 1998-03-02
GR3024895T3 (en) 1998-01-30
NO304466B1 (no) 1998-12-21
FI924914L (fi) 1993-04-30
CN1093084A (zh) 1994-10-05
ZA927692B (en) 1993-04-15
DE69221084D1 (de) 1997-08-28
ATE155691T1 (de) 1997-08-15
FI924914A0 (fi) 1992-10-29
JPH05239046A (ja) 1993-09-17
IL103353A (en) 1999-01-26
HU9203389D0 (en) 1993-01-28
EP0544412A2 (de) 1993-06-02
DE69221084T2 (de) 1998-02-26
PL296409A1 (en) 1993-11-29
CA2081637C (en) 2000-05-16
NO924157D0 (no) 1992-10-28
JP3385048B2 (ja) 2003-03-10
FI924914A7 (fi) 1993-04-30
AU662361B2 (en) 1995-08-31

Similar Documents

Publication Publication Date Title
HUT74804A (en) Process for producing rhenium- and technecium-compounds containing new molekule-stuctures for localizing hypoxia, and pharmaceutical compositions containing them
IL90815A (en) Compositions comprising quinoline derivatives, sume such novel compounds and processes for the preparation of such derivatives
IL103944A0 (en) Piperazine derivatives,their preparation and pharmaceutical compositions containing them
HU9402239D0 (en) Isoxazole-derivatives, compositions containing them and processes for their preparation
PH23293A (en) Hypotensive quinolone derivatives
HU900636D0 (en) Process for preparation of new tetrahydro-benzimidazole derivatives and pharmaceutical compositions containing the above compounds
GR3021971T3 (en) Imidazonaphthyridine derivatives
IL62181A0 (en) Benzoxazole dand benzothiazole derivatives,their preparation and pharmaceutical compositions containing them
EP0449195A3 (en) Aminobenzene compounds, their production and use
ZA896618B (en) Sulphonamidocycloalkane compounds,processes for their preparation and compositions containing them
GR860246B (en) Imidazole derivatives their preparation and their use as fungicides
SE8901060D0 (sv) New compounds
GR3020488T3 (en) Benzo(b)thiophene-2-carboxamides for the treatment of disorders of the central nervous system
DK371887D0 (da) Phytotoksicitetsbeskyttende forbindelser samt fremgangsmaade til fremstilling af herbicid komposition indeholdende samme
BG102429A (en) Derivatives of 5-naphthalen-1-yl-1,3-dioxan, their preparation and usage as therapeutical means
GR3008034T3 (de)
PT78375B (en) Process for the preparation of n-sulphenylated phenethylsulphonamides with fungicidal effects
AU675889B2 (en) Pyridazinone derivatives, processes for production thereof
ES2101269T3 (es) Nuevos derivados de 1-fenil-biciclo-(2.2.2)-octano, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE2963724D1 (en) Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee